BPC-157 / TB-500 Research Peptides

BPC-157 is a synthetic pentadecapeptide — fifteen amino acid residues — whose sequence corresponds to a partial region of a protein isolated from gastric juice, from which the name Body Protection Compound derives. It is produced synthetically for research use; it is not extracted from tissue.

The sequence GEPPPGKPADDAGLV is proline-rich, which is relevant analytically: proline-containing peptides can show characteristic chromatographic behaviour, and sequence-specific method development is normal for this class of compound.

"TB-500" is a research-supply designation rather than a formal chemical name, and it is applied inconsistently across the sector. In some catalogues it refers to full-length thymosin β4, a naturally occurring 43-residue polypeptide (CAS 77591-33-4). In others it refers to the short acetylated fragment Ac-LKKTETQ, which corresponds to the actin-binding region at residues 17–23 of thymosin β4.

These are chemically different materials with different masses and different chromatographic behaviour. Vial Drop Labs does not resolve this ambiguity by assertion: the authoritative statement of what a given batch actually contains is the third-party analytical report issued for that batch, which states the analyte characterised and the method used.

When comparing documentation between suppliers, confirm which of the two molecules a report describes before treating any two figures as comparable.

The Vial Drop Labs BPC-157 / TB-500 research blend is a co-lyophilised preparation containing 10 mg BPC-157 and 10 mg TB-500 per sealed vial, for a total peptide content of 20 mg. It is intended for laboratory workflows that examine the two compounds in parallel rather than requiring separate reconstitution of two vials.

For a blend, per-component analytical results are the meaningful ones. A single combined purity number would not describe a two-analyte preparation, so a report covering a two-peptide blend states results for each component individually against its stated label claim.

No analytical report has been published for the BPC-157 / TB-500 10mg / 10mg research blend at this time. Results published for other formulations that contain these peptides are specific to those formulations and their tested samples, and are not evidence for this material.

A Certificate of Analysis links a submitted sample to the analytical work performed on it. Current Vial Drop Labs reports are produced by validated HPLC-DAD methodology and answer two separate questions — what the material is, and how much of it is present.

Vial Drop Labs publishes independent analytical reports for tested research materials, with available reports accessible through the Research Documentation portal against the research material and the sample identified on each report. Each analytical report applies only to the sample submitted for analysis and should not be interpreted as testing of every vial or production unit.

Not every report is publicly listed. Where no report has been published for a material, the portal shows none rather than substituting another material's, strength's or batch's results. Documentation is never averaged, combined, or extrapolated between lots.

Current reports are issued by an independent third-party analytical laboratory using validated HPLC-DAD methodology. They report chromatographic purity as area %, content per vial against label claim, and identity as conforming by retention-time and UV/DAD comparison against a reference standard. Current reports do not include mass-spectrometry results.

Vial Drop Labs makes no representation that material is pharmaceutical grade, clinical grade, sterile, safe, or approved by any regulatory authority. Published documentation states exactly what was tested, by which method, and on which date — nothing further should be inferred from it.

Material is supplied lyophilised in a sealed glass vial. General laboratory practice for lyophilised peptides applies: store sealed at -20 °C for long-term storage, protect from light, and minimise exposure to atmospheric moisture.

Allow a cold sealed vial to equilibrate to ambient temperature before opening so that atmospheric moisture does not condense onto the dry cake. Lyophilised peptide material is hygroscopic, and repeated warm/cold cycling of an opened vial is the most common cause of avoidable degradation in a laboratory setting.

Handle as an uncharacterised laboratory chemical using standard laboratory protective equipment and institutional handling procedures.

This material is supplied strictly as a laboratory research chemical. It is not a drug, supplement, cosmetic, food or medical device, and it is not manufactured, labelled or sold for human or animal use of any kind.

Vial Drop Labs does not provide, and cannot provide, dosing, administration, preparation-for-use, therapeutic or clinical guidance. Published information is limited to chemical identity, laboratory handling and analytical documentation.